Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients (original) (raw)

References

  1. Armstrong RA (2006) Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21(3):175–181
    Article PubMed Google Scholar
  2. Börner K, Nygren H, Hagenhoff B, Malmberg P, Tallarek E, Mansson JE (2006) Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim Biophys Acta 1761(3):335–344
    Article PubMed Google Scholar
  3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259
    Article PubMed CAS Google Scholar
  4. Candy JM, Oakley AE, Mountfort SA, Taylor GA, Morris CM, Bishop HE, Edwardson JA (1992) The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell 74(1):109–118
    Article PubMed CAS Google Scholar
  5. Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O’Hare EO, Wood WG (2001) Amyloid beta-peptide1–40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42(8):1292–1297
    PubMed CAS Google Scholar
  6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923
    Article PubMed CAS Google Scholar
  7. Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer’s disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801(8):839–845
    Article PubMed CAS Google Scholar
  8. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801(8):846–852
    Article PubMed CAS Google Scholar
  9. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA 101(7):2070–2075
    Article PubMed CAS Google Scholar
  10. Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw J-J (1989) Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol (Berl) 77(6):645–653
    Article Google Scholar
  11. Distl R, Meske V, Ohm TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 101(6):547–554
    PubMed CAS Google Scholar
  12. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5–36
    Article PubMed CAS Google Scholar
  13. Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70(3–4):249–256
    Article CAS Google Scholar
  14. Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257
    Article PubMed CAS Google Scholar
  15. Gottfries CG, Karlsson I, Svennerholm L (1996) Membrane components separate early-onset Alzheimer’s disease from senile dementia of the Alzheimer type. Int Psychogeriatr 8(3):365–372
    Article PubMed CAS Google Scholar
  16. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O’Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093
    Article PubMed CAS Google Scholar
  17. Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84(1):45–51
    Article CAS Google Scholar
  18. Ikonen E, Parton RG (2000) Caveolins and cellular cholesterol balance. Traffic 1(3):212–217
    Article PubMed CAS Google Scholar
  19. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099
    Article PubMed CAS Google Scholar
  20. Lebouvier T, Perruchini C, Panchal M, Potier MC, Duyckaerts C (2009) Cholesterol in the senile plaque: often mentioned, never seen. Acta Neuropathol 117(1):31–34
    Article PubMed CAS Google Scholar
  21. Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease. A quantitative study of visual and auditory cortices. J Neurosci 7(6):1799–1808
    PubMed CAS Google Scholar
  22. Majocha RE, Benes FM, Reifel JL, Rodenrys AM, Marotta CA (1988) Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci USA 85(16):6182–6186
    Article PubMed CAS Google Scholar
  23. Marquer C, Devauges V, Cossec JC, Liot G, Lecart S, Saudou F, Duyckaerts C, Leveque-Fort S, Potier MC (2011) Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J 25(4):1295–1305
    Article PubMed CAS Google Scholar
  24. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11
    Article PubMed CAS Google Scholar
  25. Nygren H, Malmberg P, Kriegeskotte C, Arlinghaus HF (2004) Bioimaging TOF-SIMS: localization of cholesterol in rat kidney sections. FEBS Lett 566(1–3):291–293
    Article PubMed CAS Google Scholar
  26. Ohm TG, Treiber-Held S, Distl R, Glockner F, Schonheit B, Tamanai M, Meske V (2003) Cholesterol and tau protein—findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry 36(Suppl 2):S120–S126
    PubMed CAS Google Scholar
  27. Panchal M, Loeper J, Cossec JC, Perruchini C, Lazar A, Pompon D, Duyckaerts C (2010) Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry. J Lipid Res 51(3):598–605
    Article PubMed CAS Google Scholar
  28. Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610(2):271–280
    Article PubMed CAS Google Scholar
  29. Puglielli L, Friedlich AL, Setchell KD, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov S, Kovacs DM, Bush AI (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest 115(9):2556–2563
    Article PubMed CAS Google Scholar
  30. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6(4):345–351
    Article PubMed CAS Google Scholar
  31. Quintana C, Wu TD, Delatour B, Dhenain M, Guerquin-Kern JL, Croisy A (2007) Morphological and chemical studies of pathological human and mice brain at the subcellular level: correlation between light, electron, and nanosims microscopies. Microsc Res Tech 70(4):281–295
    Article PubMed CAS Google Scholar
  32. Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 5(10):2801–2808
    PubMed CAS Google Scholar
  33. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’s disease. Biochemistry 41(37):11080–11090
    Article PubMed CAS Google Scholar
  34. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569–572
    Article PubMed CAS Google Scholar
  35. Sjövall P, Lausmaa J, Johansson B (2004) Mass spectrometric imaging of lipids in brain tissue. Anal Chem 76(15):4271–4278
    Article PubMed Google Scholar
  36. Solé-Domènech S, Sjövall P, Vukojevic V, Codita A, Salve S, Schalling V, LaFerla F, Giménez-Llort L, Nilsson P, Hammarström P, Terenius L, Johansson B (2011) Cholesterol accumulates in the vicinity of amyloid-beta deposits in brain tissue. Paper presented at the Alzheimer’s Association International Conference, Paris
  37. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791–1800
    Article PubMed Google Scholar
  38. Touboul D, Brunelle A, Laprévote O (2006) Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. Rapid Commun Mass Spectrom 20(4):703–709
    Article PubMed CAS Google Scholar
  39. Touboul D, Halgand F, Brunelle A, Kersting R, Tallarek E, Hagenhoff B, Laprévote O (2004) Tissue molecular ion imaging by gold cluster ion bombardment. Anal Chem 76(6):1550–1559
    Article PubMed CAS Google Scholar
  40. Touboul D, Kollmer F, Niehuis E, Brunelle A, Laprévote O (2005) Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source. J Am Soc Mass Spectrom 16(10):1608–1618
    Article PubMed CAS Google Scholar
  41. Touboul D, Laprévote O, Brunelle A (2011) Micrometric molecular histology of lipids by mass spectrometry imaging. Curr Opin Chem Biol 15(5):725–732
    Article PubMed CAS Google Scholar
  42. Weibel ER (1979) Stereological methods. In: Practical methods for biological morphometry, vol 1. Academic Press, London
  43. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W (2008) Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29(3):422–437
    Article PubMed CAS Google Scholar

Download references